Health Economic Impact of Software-Assisted Brain MRI on Therapeutic Decision-Making and Outcomes of Relapsing-Remitting Multiple Sclerosis Patients-A Microsimulation Study.
Diana Maria SimaGiovanni EspositoWim Van HeckeAnnemie RibbensGuy NagelsDirk SmeetsPublished in: Brain sciences (2021)
The health economic burden of MS is high. Using assistive MRI software to detect and quantify lesions and/or brain atrophy has a significant impact on the detection of disease activity, treatment decisions, health outcomes, utilities, and costs in patients with MS.
Keyphrases
- multiple sclerosis
- disease activity
- white matter
- systemic lupus erythematosus
- rheumatoid arthritis
- public health
- end stage renal disease
- healthcare
- magnetic resonance imaging
- decision making
- rheumatoid arthritis patients
- ankylosing spondylitis
- contrast enhanced
- mental health
- ejection fraction
- mass spectrometry
- newly diagnosed
- chronic kidney disease
- resting state
- juvenile idiopathic arthritis
- health information
- peritoneal dialysis
- prognostic factors
- diffusion weighted imaging
- type diabetes
- ms ms
- magnetic resonance
- health promotion
- label free
- computed tomography
- patient reported
- insulin resistance